speb/financial-data huggingface dataset:
Stock screener scorecard for ASC (annual, report date 2025-12-31)
Altman Z-score: 2.7100548854737823 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 7.265541268428695%
Earnings yield: 7.169674222270672%
Return on net tangible assets: -7.228965045393852%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.9134342757744704%
Free cash flow margin: -13.50109768953278%
Revenue growth: -23.556128383573526%
Rule of 40 score: -37.05722607310631
Market cap: 419450871.91999996 (Small Cap ($300M-$2B))
P/E ratio: 10.227016919100794
Debt to equity: 0.20315699699055864
Free cash flow (dilution adjusted): -41880000
Operating income: 52741000
Net income: 41014000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for CEC.DE (annual, report date 2025-09-30)
Altman Z-score: 2.2700585192505205 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 20.70517629407352%
Earnings yield: 9.208432271932596%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.956709956709954%
Free cash flow margin: 3.7274618585298196%
Revenue growth: 8.854720927672387%
Rule of 40 score: 12.582182786202207
Market cap: 2130120558.7599995 (Mid Cap ($2B-$10B))
Debt to equity: 5.228865979381433
Free cash flow (dilution adjusted): 1011764705.882353
Operating income: 324705882.35294116
Net income: -40000000
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for GAW.L (annual, report date 2025-05-31)
Altman Z-score: 5.597930338068115 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 95.78445747800586%
Earnings yield: 5.470040350070963%
Return on net tangible assets: 84.44096950742768%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 81.80964308077647%
Free cash flow margin: 33.23076923076923%
Revenue growth: 25.39908179055982%
Rule of 40 score: 58.62985102132905
Market cap: 49035239.55989999 (Nano Cap (< $50M))
P/E ratio: 0.25005221601172867
Debt to equity: 0.16096866096866097
Free cash flow (dilution adjusted): 277297297.2972973
Operating income: 353108108.1081081
Net income: 265000000
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for HDSN (annual, report date 2025-12-31)
Altman Z-score: 4.479007999521249 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 10.595758042876309%
Earnings yield: 7.346633144791258%
Return on net tangible assets: 10.554270025297637%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.305197361170154%
Free cash flow margin: -3.776752333606365%
Revenue growth: 4.004757125144443%
Rule of 40 score: 0.22800479153807807
Market cap: 288171197.8 (Micro Cap ($50M-$300M))
P/E ratio: 17.289926069478607
Debt to equity: 0.021730555897941574
Free cash flow (dilution adjusted): -9314000
Operating income: 18559000
Net income: 16667000
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for HPK (annual, report date 2025-12-31)
Altman Z-score: 0.8470147795780587 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 5.157354369038527%
Earnings yield: 7.421307537096193%
Return on net tangible assets: -4.678254750970325%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.122143499254891%
Free cash flow margin: -1.294826370026837%
Revenue growth: -22.71944860921521%
Rule of 40 score: -24.014274979242046
Market cap: 598937412.96 (Small Cap ($300M-$2B))
P/E ratio: 31.584528448030376
Debt to equity: 0.7486624912437154
Free cash flow (dilution adjusted): -11179000
Operating income: 152817000
Net income: 18963000
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for NOVN.SW (annual, report date 2025-12-31)
Altman Z-score: 2.953498102471307 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 113.58310802111495%
Earnings yield: 7.89191586520913%
Return on net tangible assets: -200.88155515370704%
Capitalized R&D asset: 26105215983.524208
ROCI (R&D adjusted): 17.847204941022863%
Rosenberg metric: 1.0041768867984107
Free cash flow margin: 24.963828210466882%
Revenue growth: 24.831438180457464%
Rule of 40 score: 49.79526639092435
Market cap: 202160030382.4 (Mega Cap (>= $200B))
P/E ratio: 14.456523911784895
Debt to equity: 0.7599733614041118
Free cash flow (dilution adjusted): 17908860759.49367
Operating income: 22334177215.189873
Net income: 17701265822.78481
Long score: 9 | Short score: 3
Recommendation: Long
Stock screener scorecard for RCI (annual, report date 2025-12-31)
Altman Z-score: 0.7987848754987432 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 24.911880057588245%
Earnings yield: 5.414974164287153%
Return on net tangible assets: -37.326405593508454%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.7482517482517475%
Free cash flow margin: 9.630619012527635%
Revenue growth: 9.992673805809076%
Rule of 40 score: 19.62329281833671
Market cap: 21767525771.553802 (Large Cap ($10B-$200B))
P/E ratio: 3.1519730338189693
Debt to equity: 1.8189903648192374
Free cash flow (dilution adjusted): 1526277372.2627735
Operating income: 3662773722.627737
Net income: 5040875912.408759
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for STECH.OL (annual, report date 2025-12-31)
Altman Z-score: 2.595957609427445 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.089786229051297%
Earnings yield: 5.972366793006652%
Return on net tangible assets: -13.723196243178897%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.045552239167419%
Free cash flow margin: 3.060292782229496%
Revenue growth: 64.99086068932425%
Rule of 40 score: 68.05115347155375
Market cap: 685063584.3077691 (Small Cap ($300M-$2B))
P/E ratio: 21.378841103101017
Debt to equity: 1.1157142915149079
Free cash flow (dilution adjusted): 1220597.014925373
Operating income: 5939104.477611939
Net income: 3188457.711442786
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for TOM.OL (annual, report date 2025-12-31)
Altman Z-score: 22.011652378239436 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 21.477289217820342%
Earnings yield: 0.050964435811880184%
Return on net tangible assets: 230.5525460455038%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.244491718583802%
Free cash flow margin: 12.963665326556931%
Revenue growth: 10.285165150796912%
Rule of 40 score: 23.24883047735384
Market cap: 39498277809.004196 (Large Cap ($10B-$200B))
P/E ratio: 401.40526228662804
Debt to equity: 1.0992095499274077
Free cash flow (dilution adjusted): 17004975.124378107
Operating income: 14726368.159203978
Net income: 9791044.776119402
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 0506.HK (annual, report date 2025-12-31)
Altman Z-score: 2.733784734867343 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 30.099357165863548%
Earnings yield: 2.9728769535797888%
Return on net tangible assets: 45.908113574596435%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.413836756726564%
Free cash flow margin: 9.826810514576195%
Revenue growth: 2.427042397862882%
Rule of 40 score: 12.253852912439077
Market cap: 9230836736 (Mid Cap ($2B-$10B))
P/E ratio: 1.467437874892888
Debt to equity: 0.006500000000000001
Free cash flow (dilution adjusted): 278765167.09511566
Operating income: 244435989.71722364
Net income: 183553598.97172236
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1061.HK (annual, report date 2025-12-31)
Altman Z-score: 2.9530917266299013 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 30.13005998153475%
Earnings yield: 5.855945409629602%
Return on net tangible assets: 25.385380042915916%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.178949152401533%
Free cash flow margin: 7.261621183380236%
Revenue growth: 13.278408009315381%
Rule of 40 score: 20.540029192695616
Market cap: 1442407424 (Small Cap ($300M-$2B))
P/E ratio: 0.8400661035622474
Debt to equity: 0.1438
Free cash flow (dilution adjusted): 18815973.14285714
Operating income: 59064665.71428572
Net income: 45441594.71428572
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 1084.HK (annual, report date 2025-12-31)
Altman Z-score: 1.8998420801085438 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 4.585549421745518%
Earnings yield: 0.42926431917747565%
Return on net tangible assets: 3.959287264773624%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.8442651194556143%
Free cash flow margin: -2.3834683703810144%
Revenue growth: -8.783630667655958%
Rule of 40 score: -11.167099038036973
Market cap: 598637120 (Small Cap ($300M-$2B))
P/E ratio: 8.354755784061696
Debt to equity: 0.6999
Free cash flow (dilution adjusted): -2771593.83033419
Operating income: 4789588.688946015
Net income: 846786.6323907454
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 2111.HK (annual, report date 2025-12-31)
Altman Z-score: 2.5965370746427334 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.663491904146433%
Earnings yield: 3.134336225175103%
Return on net tangible assets: 2.9330259899616666%
Capitalized R&D asset: 29698514.872798435
ROCI (R&D adjusted): 13.91226160919928%
Rosenberg metric: 0.3533362437111061
Free cash flow margin: 12.198127936613465%
Revenue growth: 3.453021716936646%
Rule of 40 score: 15.651149653550112
Market cap: 2474743040 (Mid Cap ($2B-$10B))
P/E ratio: 0.7493815783091623
Debt to equity: 0.4255
Free cash flow (dilution adjusted): 87493285.71428572
Operating income: 100161285.71428572
Net income: 81087142.85714285
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 2172.HK (annual, report date 2025-12-31)
Altman Z-score: 11.437744283328 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 20.52560778012231%
Earnings yield: 1.0719993587796417%
Return on net tangible assets: 15.005633578510515%
Capitalized R&D asset: 27650883.818441544
ROCI (R&D adjusted): 13.296227448987667%
Rosenberg metric: 0.5149358725683836
Free cash flow margin: 17.161912400393177%
Revenue growth: 8.217637904902416%
Rule of 40 score: 25.379550305295595
Market cap: 4962819584 (Mid Cap ($2B-$10B))
P/E ratio: 3.755297714166609
Debt to equity: 0.0089
Free cash flow (dilution adjusted): 19380285.714285713
Operating income: 43703857.14285714
Net income: 26358571.42857143
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2382.HK (annual, report date 2025-12-31)
Altman Z-score: 2.5264725339143674 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 14.331135967116223%
Earnings yield: 1.1519012761384244%
Return on net tangible assets: 15.150378864939668%
Capitalized R&D asset: 853007832.3573369
ROCI (R&D adjusted): 10.871073536604223%
Rosenberg metric: 0.6411595279972028
Free cash flow margin: 6.74807304686197%
Revenue growth: 17.723990191099354%
Rule of 40 score: 24.472063237961322
Market cap: 62678102016 (Large Cap ($10B-$200B))
P/E ratio: 1.6874098689573014
Debt to equity: 0.20980000000000001
Free cash flow (dilution adjusted): 416733285.7142857
Operating income: 535844285.71428573
Net income: 686712857.1428572
Long score: 10 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 2457.HK (annual, report date 2025-12-31)
Altman Z-score: 4.565399391700395 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 2.022108835419958%
Earnings yield: 0.8398638455118382%
Return on net tangible assets: 0.8294717894455181%
Capitalized R&D asset: 3913781.6633225167
ROCI (R&D adjusted): 2.4438539253095017%
Rosenberg metric: -0.22482097174069812
Free cash flow margin: 2.248120802219219%
Revenue growth: 7.7033653599099345%
Rule of 40 score: 9.951486162129154
Market cap: 365000000 (Small Cap ($300M-$2B))
P/E ratio: 3.727506426735218
Debt to equity: 0.015
Free cash flow (dilution adjusted): 1300142.857142857
Operating income: 1210428.5714285714
Net income: 1580571.4285714286
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for 4043.T (annual, report date 2026-03-31)
Altman Z-score: 2.3484853811153736 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 11.88773094164017%
Earnings yield: 0.04575351032664486%
Return on net tangible assets: 7.711620418169493%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.658869704247613%
Free cash flow margin: 6.259085030159439%
Revenue growth: -4.646860762760287%
Rule of 40 score: 1.612224267399152
Market cap: 326990757888 (Mega Cap (>= $200B))
P/E ratio: 0.0757781208835938
Debt to equity: 0.544
Free cash flow (dilution adjusted): 136849349.34934935
Operating income: 208883883.8838839
Net income: 140990990.990991
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 4345.T (annual, report date 2026-03-31)
Altman Z-score: 6.512339158945668 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 40.975431768426176%
Earnings yield: 0.0631927318741337%
Return on net tangible assets: 21.756861729673744%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 18.52116547553601%
Free cash flow margin: 22.805365968463168%
Revenue growth: 0.9387559880327035%
Rule of 40 score: 23.74412195649587
Market cap: 35639521280 (Large Cap ($10B-$200B))
P/E ratio: 0.08676419346776049
Debt to equity: 0.1167
Free cash flow (dilution adjusted): 18186936.936936937
Operating income: 21077327.327327326
Net income: 16804304.304304305
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 5020.T (annual, report date 2026-03-31)
Altman Z-score: 2.3900168316068298 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.100860285081039%
Earnings yield: 0.04249116452601614%
Return on net tangible assets: 14.251625107456894%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.041076594876025%
Free cash flow margin: 3.0912662222588647%
Revenue growth: -10.625248978964144%
Rule of 40 score: -7.53398275670528
Market cap: 3523641081856 (Mega Cap (>= $200B))
P/E ratio: 0.09195966495883129
Debt to equity: 0.696
Free cash flow (dilution adjusted): 2275412912.912913
Operating income: 2412443693.6936936
Net income: 1922053303.3033032
Long score: 7 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 7247.T (annual, report date 2026-03-31)
Altman Z-score: 1.6455820792014544 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 7.9181107134064375%
Earnings yield: 0.05550109921139329%
Return on net tangible assets: 6.545556461475743%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.357968369829684%
Free cash flow margin: 5.832583954592483%
Revenue growth: -4.556435231027061%
Rule of 40 score: 1.2761487235654219
Market cap: 12239531008 (Large Cap ($10B-$200B))
P/E ratio: 0.0662530508036126
Debt to equity: 0.8851
Free cash flow (dilution adjusted): 37737737.73773774
Operating income: 26157407.407407407
Net income: 7676426.4264264265
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9307.T (annual, report date 2026-03-31)
Altman Z-score: 3.8612055766853937 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 7.535812590957529%
Earnings yield: 0.06542035703073051%
Return on net tangible assets: 7.4267617642181705%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.744865301512163%
Free cash flow margin: 10.986015090093595%
Revenue growth: -6.335608144054622%
Rule of 40 score: 4.650406946038973
Market cap: 16758974464 (Large Cap ($10B-$200B))
P/E ratio: 0.1075640747993391
Debt to equity: 0.1352
Free cash flow (dilution adjusted): 7727102.102102102
Operating income: 8827152.152152153
Net income: 6052195.945945946
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for AHCL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.929215156625715 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 5.804653257907449%
Earnings yield: 0.02147839558478149%
Return on net tangible assets: 629.0549120755995%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.630530699393467%
Revenue growth: 36.07756596799499%
Rule of 40 score: 36.07756596799499
Market cap: 7978040320 (Mid Cap ($2B-$10B))
P/E ratio: 0.19268089345818964
Debt to equity: 0.17129999999999998
Operating income: 1589624.8410343365
Net income: 153419997.88045782
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AHCL.NS (annual, report date 2026-03-31)
Altman Z-score: 5.5264707294051 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 17.798390298759866%
Earnings yield: 0.0658576577486925%
Return on net tangible assets: 9.136995412734427%
Capitalized R&D asset: 2851.577695929919
ROCI (R&D adjusted): 17.255574559413496%
Rosenberg metric: 700.2415402404536
Free cash flow margin: -67.40109649836944%
Revenue growth: 29.600191621473638%
Rule of 40 score: -37.8009048768958
Market cap: 7978040320 (Mid Cap ($2B-$10B))
P/E ratio: 0.19268089345818964
Debt to equity: 0.17129999999999998
Free cash flow (dilution adjusted): -12283456.973293768
Operating income: 4874152.1831284445
Net income: 5926907.587961
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for APM.TO (quarterly, report date 2026-03-31)
Altman Z-score: 5.286982641890125 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 22.433846949609343%
Earnings yield: 5.966915032928559%
Return on net tangible assets: 16.7100287807607%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.337399200043613%
Free cash flow margin: 22.73724865129966%
Revenue growth: 20.25982110607368%
Rule of 40 score: 42.99706975737334
Market cap: 926271616 (Small Cap ($300M-$2B))
P/E ratio: 3.5460992907801425
Debt to equity: 0.1402
Free cash flow (dilution adjusted): 26682733.812949643
Operating income: 47428057.55395684
Net income: 34709352.51798561
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BLSH (quarterly, report date 2026-03-31)
Altman Z-score: 19.02288756202444 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0.25200522816816645%
Earnings yield: 0.20240901690730123%
Return on net tangible assets: -22.685938644316057%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.24258866956095884%
Free cash flow margin: 0.1619445327684981%
Revenue growth: -19.45775823406472%
Rule of 40 score: -19.295813701296222
Market cap: 3633494272 (Mid Cap ($2B-$10B))
Debt to equity: 0.18760000000000002
Free cash flow (dilution adjusted): 84001000
Operating income: 7772000
Net income: -581713000
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CAP.PA (annual, report date 2025-12-31)
Altman Z-score: 1.996577438879603 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 72.36689814814817%
Earnings yield: 11.638481080565569%
Return on net tangible assets: -48.273464658169175%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.794388116010376%
Free cash flow margin: 8.586690407300246%
Revenue growth: 14.827277761213098%
Rule of 40 score: 23.413968168513343
Market cap: 15063058432 (Large Cap ($10B-$200B))
P/E ratio: 14.211687425936526
Debt to equity: 0.8103152844413981
Free cash flow (dilution adjusted): 2269411764.7058825
Operating income: 2942352941.1764708
Net income: 1890588235.2941177
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for CELLO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 16.803742248907657 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.057281700289309%
Earnings yield: 0.016736678185298618%
Return on net tangible assets: 4.067151526868888%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.9940759935524697%
Revenue growth: 12.30613347809794%
Rule of 40 score: 12.30613347809794
Market cap: 76050718720 (Large Cap ($10B-$200B))
P/E ratio: 0.2788412262984957
Debt to equity: 0.0141
Operating income: 11578041.543026706
Net income: 9550922.000847816
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CELLO.NS (annual, report date 2026-03-31)
Altman Z-score: 17.673272013424135 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 14.649752586567963%
Earnings yield: 0.0604316418350125%
Return on net tangible assets: 7.09637406718301%
Capitalized R&D asset: 144187.7760732746
ROCI (R&D adjusted): 14.399831793230334%
Rosenberg metric: -59.26909938121881
Free cash flow margin: 1.5377750361824738%
Revenue growth: -1.398696273105276%
Rule of 40 score: 0.1390787630771979
Market cap: 76050718720 (Large Cap ($10B-$200B))
P/E ratio: 0.2788412262984957
Debt to equity: 0.0141
Free cash flow (dilution adjusted): 3786922.4247562527
Operating income: 41805192.87833828
Net income: 35132089.86858839
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for GPIL.NS (annual, report date 2026-03-31)
Altman Z-score: 7.992937676120838 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 19.208002545029508%
Earnings yield: 0.08102840064239317%
Return on net tangible assets: -1.7609444685534432%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.719092244125846%
Free cash flow margin: 1.063997844126639%
Revenue growth: -9.264213324618039%
Rule of 40 score: -8.2002154804914
Market cap: 156240969728 (Large Cap ($10B-$200B))
P/E ratio: 0.22544048958159657
Debt to equity: 0.0758
Free cash flow (dilution adjusted): 6067189.487070792
Operating income: 113896778.2958881
Net income: 84966087.32513776
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for GPIL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 7.1667563339061084 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.981316194894928%
Earnings yield: 0.029450479524095925%
Return on net tangible assets: 5.727252288757248%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.076700019912385%
Revenue growth: 34.44563978393226%
Rule of 40 score: 34.44563978393226
Market cap: 156240969728 (Large Cap ($10B-$200B))
P/E ratio: 0.22544048958159657
Debt to equity: 0.0758
Operating income: 41396778.29588809
Net income: 29697965.239508267
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IBS.LS (quarterly, report date 2026-03-31)
Altman Z-score: 1.3784113312372495 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0.14637251418982314%
Earnings yield: 0.12053173921358656%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.10829215997680244%
Free cash flow margin: 10.91456050765624%
Revenue growth: -12.067467047624799%
Rule of 40 score: -1.1529065399685585
Market cap: 373678720 (Small Cap ($300M-$2B))
P/E ratio: 29.109195402298848
Debt to equity: 0.8956000000000001
Free cash flow (dilution adjusted): 15211849.425287357
Operating income: 659454.0229885058
Net income: -2918532.183908046
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for IRDM (quarterly, report date 2026-06-30)
Altman Z-score: 1.4240538564005354 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.5682375634583308%
Earnings yield: 0.5267781651617854%
Return on net tangible assets: 14.33673767544508%
Capitalized R&D asset: 11355520
ROCI (R&D adjusted): 1.390080655813921%
Rosenberg metric: 0.6540330417881438
Free cash flow margin: 33.27739225793275%
Revenue growth: 2.821183527575015%
Rule of 40 score: 36.09857578550777
Market cap: 4850866176 (Mid Cap ($2B-$10B))
P/E ratio: 63.04597701149425
Debt to equity: 3.7866000000000004
Free cash flow (dilution adjusted): 74953000
Operating income: 34008000
Net income: 9679000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for JSWSTEEL.NS (annual, report date 2026-03-31)
Altman Z-score: 2.6503810687449265 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 13.491724074159691%
Earnings yield: 0.06874845292855175%
Return on net tangible assets: 21.198503416786057%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.65507566188548%
Free cash flow margin: 5.675219872882985%
Revenue growth: -0.9325096161939457%
Rule of 40 score: 4.742710256689039
Market cap: 3171359129600 (Mega Cap (>= $200B))
P/E ratio: 0.12904751305835863
Debt to equity: 0.9416
Free cash flow (dilution adjusted): 1094849512.5052989
Operating income: 2474035608.308605
Net income: 2703264094.9554896
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for MPLX (quarterly, report date 2026-03-31)
Altman Z-score: 1.400883574953533 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 4.520565946822025%
Earnings yield: 1.223210706949246%
Return on net tangible assets: 17.73138832997988%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.5968143730655995%
Free cash flow margin: 27.51247327156094%
Revenue growth: -3.04077401520387%
Rule of 40 score: 24.47169925635707
Market cap: 59514134528 (Large Cap ($10B-$200B))
P/E ratio: 12.116883116883116
Debt to equity: 1.8278999999999999
Free cash flow (dilution adjusted): 772000000
Operating income: 1032000000
Net income: 922000000
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NESTLEIND.NS (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 68.14678872250819%
Earnings yield: 0.01779861737930153%
Capitalized R&D asset: 22316658.273969904
ROCI (R&D adjusted): 2219.2458827148425%
Rosenberg metric: 1.7665321951910595
Rule of 40 score: 0
Market cap: 2683827912704 (Mega Cap (>= $200B))
P/E ratio: 0.6777870789265599
Debt to equity: 0.0861
Operating income: 493869224.2475625
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NTES (quarterly, report date 2026-03-31)
Altman Z-score: 6.10771110176034 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 9.070863109567158%
Earnings yield: 0.8068512037082978%
Return on net tangible assets: 6.823402628177898%
Capitalized R&D asset: 1283578923.1408525
ROCI (R&D adjusted): 6.9554150424850105%
Rosenberg metric: 0.8571984770757762
Free cash flow margin: 40.90944736835309%
Revenue growth: 12.497733455113345%
Rule of 40 score: 53.40718082346643
Market cap: 76541911040 (Large Cap ($10B-$200B))
P/E ratio: 14.248399487836108
Debt to equity: 0.0647
Free cash flow (dilution adjusted): 1811103328.5094066
Operating income: 1831669030.390738
Net income: 1569551953.6903038
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for OFN.SW (annual, report date 2025-12-31)
Altman Z-score: 5.477812380355694 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 20.774004592275595%
Earnings yield: 16.554327113465696%
Return on net tangible assets: 15.846318233182407%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.385460407172282%
Free cash flow margin: 11.363344782208669%
Revenue growth: 23.066755686278036%
Rule of 40 score: 34.43010046848671
Market cap: 279300000 (Micro Cap ($50M-$300M))
P/E ratio: 15.080029291766921
Debt to equity: 0
Free cash flow (dilution adjusted): 39240506.32911392
Operating income: 36991139.24050633
Net income: 29059493.670886073
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PASUPTAC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.628242405459546 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 6.71133339624422%
Earnings yield: 0.07966995016335965%
Return on net tangible assets: 6.768177851270038%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.450910674116536%
Revenue growth: -13.557054449332584%
Rule of 40 score: -13.557054449332584
Market cap: 5161698816 (Mid Cap ($2B-$10B))
P/E ratio: 0.05502807791189909
Debt to equity: 0.24600000000000002
Operating income: 3768545.994065282
Net income: 2785078.423060619
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for PASUPTAC.NS (annual, report date 2026-03-31)
Altman Z-score: 4.15526633820946 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 18.614702274228552%
Earnings yield: 0.22097433027593255%
Return on net tangible assets: 15.240457489320654%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.89238807053189%
Free cash flow margin: 3.509345054248832%
Revenue growth: 47.35988225873789%
Rule of 40 score: 50.86922731298672
Market cap: 5161698816 (Mid Cap ($2B-$10B))
P/E ratio: 0.05502807791189909
Debt to equity: 0.24600000000000002
Free cash flow (dilution adjusted): 3756888.5120813902
Operating income: 10452522.255192878
Net income: 7409919.457397202
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SARDAEN.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.273670045321567 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.6329712959718905%
Earnings yield: 0.015205170279466485%
Return on net tangible assets: 3.3994037102473493%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.495574727192399%
Revenue growth: -6.434202201984357%
Rule of 40 score: -6.434202201984357
Market cap: 176983490560 (Large Cap ($10B-$200B))
P/E ratio: 0.17163873939286706
Debt to equity: 0.35200000000000004
Operating income: 27476685.03603222
Net income: 16743323.442136498
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for SARDAEN.NS (annual, report date 2026-03-31)
Altman Z-score: 4.0055251641796845 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 14.690897273802813%
Earnings yield: 0.08483859848683536%
Return on net tangible assets: 15.393937720848056%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.92428091121637%
Free cash flow margin: 24.7533559187492%
Revenue growth: 11.101816444595732%
Rule of 40 score: 35.855172363344934
Market cap: 176983490560 (Large Cap ($10B-$200B))
P/E ratio: 0.17163873939286706
Debt to equity: 0.35200000000000004
Free cash flow (dilution adjusted): 148052140.73760068
Operating income: 153308605.34124628
Net income: 117575243.74735057
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SNA (quarterly, report date 2026-06-30)
Altman Z-score: 6.95926183735648 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 8.703976816993972%
Earnings yield: 1.6334247394450976%
Return on net tangible assets: 6.400264200792602%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.593745732623241%
Free cash flow margin: 17.90530416541804%
Revenue growth: 2.025529312848735%
Rule of 40 score: 19.930833478266777
Market cap: 20903964672 (Large Cap ($10B-$200B))
P/E ratio: 20.530612244897956
Debt to equity: 0.21600000000000003
Free cash flow (dilution adjusted): 239000000
Operating income: 336400000
Net income: 266200000
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for SYNCOMF.NS (quarterly, report date 2026-03-31)
Altman Z-score: 7.095293735677748 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 6.172160975353832%
Earnings yield: 0.01866032350181212%
Return on net tangible assets: 6.670837844806607%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.540390412522663%
Revenue growth: 11.884858211470476%
Rule of 40 score: 11.884858211470476
Market cap: 12304600064 (Large Cap ($10B-$200B))
P/E ratio: 0.1341638466207644
Debt to equity: 0.0036
Operating income: 2069637.5582874098
Net income: 2667910.1314116153
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SYNCOMF.NS (annual, report date 2026-03-31)
Altman Z-score: 8.075495636903048 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 22.40717786187502%
Earnings yield: 0.06774372692722272%
Return on net tangible assets: 17.197764254949035%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.483260229601363%
Free cash flow margin: 9.487347484471192%
Revenue growth: -4.637475532697702%
Rule of 40 score: 4.84987195177349
Market cap: 12304600064 (Large Cap ($10B-$200B))
P/E ratio: 0.1341638466207644
Debt to equity: 0.0036
Free cash flow (dilution adjusted): 4918334.039847393
Operating income: 7513533.276812209
Net income: 8100678.253497245
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for WSP.TO (quarterly, report date 2026-03-31)
Altman Z-score: 1.2805424858416274 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 14.618651503983719%
Earnings yield: 1.0039696240299196%
Return on net tangible assets: -5.327179707344997%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1788372908133105%
Free cash flow margin: 1.5052629265827235%
Revenue growth: -7.59930157684691%
Rule of 40 score: -6.094038650264187
Market cap: 21724352512 (Large Cap ($10B-$200B))
P/E ratio: 21.203882732831474
Debt to equity: 0.8704000000000001
Free cash flow (dilution adjusted): 49280575.53956835
Operating income: 299640287.7697842
Net income: 103669064.74820144
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 8008.T (annual, report date 2026-02-28)
Altman Z-score: 2.7810882439165496 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.710049855680923%
Earnings yield: 0.031599145162428295%
Return on net tangible assets: 11.11111111111111%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.0748646642405815%
Free cash flow margin: 0.5617335124782025%
Revenue growth: 46.695282111265726%
Rule of 40 score: 47.25701562374393
Market cap: 39492120420 (Large Cap ($10B-$200B))
P/E ratio: 22.038013627232143
Debt to equity: 0.31479361987093635
Free cash flow (dilution adjusted): 2521493.6481457716
Operating income: 17984088.284357756
Net income: 11497497.754394969
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for 9264.T (annual, report date 2025-08-31)
Altman Z-score: 1.5652101923165973 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 12.781499624155575%
Earnings yield: 0.04659040592077387%
Return on net tangible assets: -11.206649431369128%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.355041915419708%
Free cash flow margin: -2.451470913197608%
Revenue growth: 19.247995647145054%
Rule of 40 score: 16.796524733947447
Market cap: 7856728920 (Mid Cap ($2B-$10B))
P/E ratio: 13.69858741192901
Debt to equity: 2.049117539454073
Free cash flow (dilution adjusted): -1689140.9496559713
Operating income: 6212337.352680701
Net income: 3907234.8252605763
Long score: 3 | Short score: 8
Recommendation: Short
Stock screener scorecard for APM.TO (annual, report date 2025-12-31)
Altman Z-score: 8.02556303641359 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 45.22870430329075%
Earnings yield: 10.583176535247627%
Return on net tangible assets: 52.545100827401924%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 32.64962107798003%
Free cash flow margin: 15.409071581621166%
Revenue growth: 47.86844358871197%
Rule of 40 score: 63.27751517033313
Market cap: 1469985476.1599998 (Small Cap ($300M-$2B))
P/E ratio: 12.440740664359042
Debt to equity: 0.1709703847554315
Free cash flow (dilution adjusted): 40471532.84671532
Operating income: 84120437.95620437
Net income: 86247445.25547445
Long score: 14 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BLSH (annual, report date 2025-12-31)
Altman Z-score: 67.36368618556018 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.3682291777795845%
Earnings yield: 1.3193307240744947%
Return on net tangible assets: -24.54861770628705%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3238672949716093%
Free cash flow margin: -0.01606643560521338%
Revenue growth: -2.1149413751916883%
Rule of 40 score: -2.131007810796902
Market cap: 5742922863.0199995 (Mid Cap ($2B-$10B))
Debt to equity: 0.1761755725399134
Free cash flow (dilution adjusted): -39358000
Operating income: 50659000
Net income: -764681000
Long score: 4 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for CURY.L (annual, report date 2025-04-30)
Altman Z-score: 1.8832986104790572 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 31.78170144462279%
Earnings yield: 10.513706049522742%
Return on net tangible assets: -150.94339622641508%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.147159267308289%
Free cash flow margin: 4.146565586951527%
Revenue growth: 9.561113732892874%
Rule of 40 score: 13.707679319844402
Market cap: 11266887.7979 (Nano Cap (< $50M))
P/E ratio: 0.10432303516574074
Debt to equity: 0.4302273740526081
Free cash flow (dilution adjusted): 481333333.3333333
Operating income: 264000000
Net income: 144000000
Long score: 11 | Short score: 3
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EZJ.L (annual, report date 2025-09-30)
Altman Z-score: 1.2627467870698623 (Distress Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 11.19605032648511%
Earnings yield: 22.514302677651518%
Return on net tangible assets: 12.064539787312063%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.5581237253569%
Free cash flow margin: 5.798535523451414%
Revenue growth: 10.028655790821444%
Rule of 40 score: 15.82719131427286
Market cap: 33788183.42639999 (Nano Cap (< $50M))
P/E ratio: 0.06839713244210525
Debt to equity: 0.8364779874213837
Free cash flow (dilution adjusted): 791891891.8918918
Operating income: 950000000
Net income: 667567567.5675676
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for GRRR (annual, report date 2025-12-31)
Altman Z-score: 2.1527201924331494 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 4.702588933953848%
Earnings yield: 5.012942188647803%
Return on net tangible assets: -5.462716362330017%
Capitalized R&D asset: 7463200.052493158
ROCI (R&D adjusted): 4.216708744447644%
Rosenberg metric: -0.32485035486985414
Free cash flow margin: -33.90783862026467%
Revenue growth: 46.74323677006403%
Rule of 40 score: 12.83539814979936
Market cap: 224302595.8992 (Micro Cap ($50M-$300M))
Debt to equity: 0.07711258881643615
Free cash flow (dilution adjusted): -46444875.675675675
Operating income: 11477409.45945946
Net income: -15238645.945945946
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for IBS.LS (annual, report date 2025-12-31)
Altman Z-score: 2.077376822194272 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.7004407677259525%
Earnings yield: 6.628925784351801%
Return on net tangible assets: 38.50372502359659%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.756784832850722%
Free cash flow margin: 17.092081297675428%
Revenue growth: 26.089074230374727%
Rule of 40 score: 43.181155528050155
Market cap: 370093301.34999996 (Small Cap ($300M-$2B))
P/E ratio: 24.337912706395937
Debt to equity: 0.9098547555676518
Free cash flow (dilution adjusted): 106476820
Operating income: 36268221.17647059
Net income: 17889943.529411767
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for IRDM (annual, report date 2025-12-31)
Altman Z-score: 1.0279884409965707 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 11.01173782749864%
Earnings yield: 3.65529026743349%
Return on net tangible assets: 81.0533733241788%
Capitalized R&D asset: 45489510
ROCI (R&D adjusted): 9.449812257594612%
Rosenberg metric: 0.8282668355499261
Free cash flow margin: 28.476043957556797%
Revenue growth: 4.932934624802271%
Rule of 40 score: 33.40897858235907
Market cap: 1824637795.26 (Small Cap ($300M-$2B))
P/E ratio: 15.9535357890043
Debt to equity: 3.8057198443579767
Free cash flow (dilution adjusted): 248214000
Operating income: 235980000
Net income: 114372000
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for MPLX (annual, report date 2025-12-31)
Altman Z-score: 1.7506605439470277 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 20.74222493248541%
Earnings yield: 5.64431142101968%
Return on net tangible assets: 108.33935888165823%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.978066203843445%
Free cash flow margin: 35.741676834582535%
Revenue growth: 5.2274394717534856%
Rule of 40 score: 40.96911630633602
Market cap: 52096429133.46001 (Large Cap ($10B-$200B))
P/E ratio: 10.520280519680938
Debt to equity: 1.8007984581497798
Free cash flow (dilution adjusted): 4101000000
Operating income: 4762000000
Net income: 4952000000
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NTES (annual, report date 2025-12-31)
Altman Z-score: 9.153394713007108 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 26.15833684363189%
Earnings yield: 2.255039770828096%
Return on net tangible assets: 23.47780900073804%
Capitalized R&D asset: 4904865482.949789
ROCI (R&D adjusted): 18.013611597871705%
Rosenberg metric: 0.5533709120531508
Free cash flow margin: 39.99054408551319%
Revenue growth: 11.546003182898037%
Rule of 40 score: 51.536547268411226
Market cap: 607098040851.12 (Mega Cap (>= $200B))
P/E ratio: 17.446456959762727
Debt to equity: 0.04076062138503251
Free cash flow (dilution adjusted): 6434239000
Operating income: 5119266714.285714
Net income: 4971112000
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for SNA (annual, report date 2025-12-31)
Altman Z-score: 7.283745505709065 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 32.223381792587915%
Earnings yield: 6.4467836699205%
Return on net tangible assets: 24.615519817207137%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.717312978729083%
Free cash flow margin: 18.94455111421423%
Revenue growth: 0.9337561663143059%
Rule of 40 score: 19.87830728052854
Market cap: 17592394872.4 (Large Cap ($10B-$200B))
P/E ratio: 16.87843698781541
Debt to equity: 0.2168781896320172
Free cash flow (dilution adjusted): 976800000
Operating income: 1327700000
Net income: 1042300000
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for WSP.TO (annual, report date 2025-12-31)
Altman Z-score: 3.242678574637392 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 56.71069041604042%
Earnings yield: 4.3371705933946885%
Return on net tangible assets: -124.83412322274879%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.841138843262156%
Free cash flow margin: 11.447087776866285%
Revenue growth: 18.0555392514785%
Rule of 40 score: 29.502627028344783
Market cap: 33375206408.16 (Large Cap ($10B-$200B))
P/E ratio: 34.61081241124132
Debt to equity: 0.4942844078646548
Free cash flow (dilution adjusted): 1527810218.978102
Operating income: 1294452554.7445254
Net income: 703868613.1386861
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 0151.HK (annual, report date 2026-03-31)
Altman Z-score: 5.525970618128236 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 32.484672538059314%
Earnings yield: 1.895157077300586%
Return on net tangible assets: 18.65126761634395%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 23.512961495347962%
Free cash flow margin: 14.40732045622527%
Revenue growth: 2.9909237504410804%
Rule of 40 score: 17.398244206666348
Market cap: 40557436928 (Large Cap ($10B-$200B))
P/E ratio: 1.5473952738990335
Debt to equity: 0.1413
Free cash flow (dilution adjusted): 448403316.32653064
Operating income: 606320280.612245
Net income: 489422193.877551
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 0887.HK (annual, report date 2025-12-31)
Altman Z-score: 3.0273639954084857 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 10.23883466825805%
Earnings yield: 6.036332384937224%
Return on net tangible assets: 13.039539385131201%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.065864202930674%
Free cash flow margin: 16.786050471970317%
Revenue growth: 9.944823376352009%
Rule of 40 score: 26.730873848322325
Market cap: 2031878272 (Mid Cap ($2B-$10B))
P/E ratio: 0.4712939160239931
Debt to equity: 0.1042
Free cash flow (dilution adjusted): 124391516.70951156
Operating income: 78684575.83547558
Net income: 58924935.732647814
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 2131.HK (annual, report date 2023-12-31)
Altman Z-score: 1.9920513400751134 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.20500202469441%
Earnings yield: 3.2114543368718724%
Return on net tangible assets: 0.420876348291705%
Capitalized R&D asset: 4338296.645689916
ROCI (R&D adjusted): 5.682129570162805%
Rosenberg metric: 24.426644076214963
Free cash flow margin: 3.9006728150620735%
Revenue growth: -10.987446247651713%
Rule of 40 score: -7.08677343258964
Market cap: 362024384 (Small Cap ($300M-$2B))
P/E ratio: 48.5860722427084
Debt to equity: 0.31620000000000004
Free cash flow (dilution adjusted): 16512798.87482419
Operating income: 10172433.192686357
Net income: 1237130.8016877638
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2361.HK (annual, report date 2025-12-31)
Altman Z-score: 13.885930619383565 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 15.376792041630221%
Earnings yield: 0.965911967399803%
Return on net tangible assets: 13.34477811563279%
Capitalized R&D asset: 19289565.031748783
ROCI (R&D adjusted): 12.521900895361718%
Rosenberg metric: 0.40953049976069533
Free cash flow margin: 15.849578849411818%
Revenue growth: 8.25382435699282%
Rule of 40 score: 24.103403206404636
Market cap: 2155079680 (Mid Cap ($2B-$10B))
P/E ratio: 2.8759640102827766
Debt to equity: 0.0106
Free cash flow (dilution adjusted): 9489142.857142856
Operating income: 14816857.142857144
Net income: 13499857.142857144
Long score: 9 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 2475.T (annual, report date 2026-03-31)
Altman Z-score: 5.6866573466970936 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 13.017494196486185%
Earnings yield: 0.14927967439936304%
Return on net tangible assets: -1.3966610512344668%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.467562729649675%
Free cash flow margin: -2.0385097023684633%
Revenue growth: -7.916287701916018%
Rule of 40 score: -9.95479740428448
Market cap: 34625253376 (Large Cap ($10B-$200B))
P/E ratio: 0.06742397701533845
Debt to equity: 0
Free cash flow (dilution adjusted): -6415615.615615616
Operating income: 27930605.605605606
Net income: 18635942.192192193
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 5857.T (annual, report date 2026-03-31)
Altman Z-score: 2.350183883527156 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.668907863620404%
Earnings yield: 0.05037173107127763%
Return on net tangible assets: 10.678661464454708%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.407607411258684%
Revenue growth: 5.400182199975168%
Rule of 40 score: 5.400182199975168
Market cap: 264709128192 (Mega Cap (>= $200B))
P/E ratio: 0.07311969532411251
Debt to equity: 0.7946
Operating income: 220414164.16416416
Net income: 152909159.15915915
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 6237.T (annual, report date 2026-03-31)
Altman Z-score: 7.315206009831122 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.597380363997459%
Earnings yield: 0.03482344163159524%
Return on net tangible assets: 8.823252003898574%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.736348140016737%
Free cash flow margin: 5.260246026328698%
Revenue growth: -2.448232304630207%
Rule of 40 score: 2.812013721698491
Market cap: 110694883328 (Large Cap ($10B-$200B))
P/E ratio: 0.07164024521632519
Debt to equity: 0.0978
Free cash flow (dilution adjusted): 15695270.27027027
Operating income: 37066641.64164164
Net income: 30688795.045045044
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 6455.T (annual, report date 2026-03-31)
Altman Z-score: 3.8771668512432687 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 16.960475652431466%
Earnings yield: 0.12668986492265946%
Return on net tangible assets: 11.693153423288356%
Capitalized R&D asset: 31436390.13635154
ROCI (R&D adjusted): 13.332526250431249%
Rosenberg metric: 0.5549149464590637
Free cash flow margin: 2.8131325259871693%
Revenue growth: -2.328579440792287%
Rule of 40 score: 0.48455308519488227
Market cap: 100626677760 (Large Cap ($10B-$200B))
P/E ratio: 0.07441693206200148
Debt to equity: 0.0089
Free cash flow (dilution adjusted): 20520520.52052052
Operating income: 96727977.97797798
Net income: 59690940.94094094
Long score: 9 | Short score: 0
Recommendation: Long